Halloween graveyard
Biotech

The 2026 Biotech Graveyard

Join us for our annual ritual as we remember the biotechs lost this year to a tough funding environment or disappointing clinical trial readouts.
topic report
National Breast Cancer Awareness Month pink ribbon

After Enhertu: The slow hunt for next-gen HER2 breast cancer drugs

Oct 28, 2026 9:00am
ESMO 2026

From RAS rivalry to leaked readouts, ESMO brought the data drama

Oct 27, 2026 8:00am
GSK HQ London

GSK plans ‘some limited impact’ to UK roles from restructuring

Oct 28, 2026 6:33am
Three trial wins

Genmab's $8B Merus bet delivers phase 3 bispecific combo win

Oct 28, 2026 4:33pm
FDA

FDA’s rare disease framework aims to ‘stand the test of time’

Oct 28, 2026 3:16pm
More News

Biogen CEO ramps up strategy for early-stage R&D

Oct 28, 2026 11:00am

Syntax programs stem cells into pancreatic beta cells in 4 days

Oct 28, 2026 9:00am

Lilly’s retatrutide tops Ozempic in ph. 3 diabetes showdown

Oct 28, 2026 7:45am

Astellas makes $1.3B bet on Audax’s preclinical IL-12 program

Oct 28, 2026 5:37am